The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment
Recruitment status was Recruiting
To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification in patients on coumadin and antiaggregant treatments.
Design: Consecutive prospective study.
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment|
- safety and efficacy of cataract surgery with phacoemulsification under coumadin and antiaggregant treatment [ Time Frame: 3.5 years ] [ Designated as safety issue: Yes ]
- other complications [ Time Frame: 3.5 years ] [ Designated as safety issue: Yes ]
|Study Start Date:||July 2007|
|Estimated Study Completion Date:||December 2010|
|Primary Completion Date:||August 2008 (Final data collection date for primary outcome measure)|
patients under coumadin and antiaggregants operated by phacoemulsification
Procedure: cataract surgery with phacoemulsification
removal of cataract with phacoemulsification technique
To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification technique in patients on coumadin and antiaggregant treatment Design: Consecutive prospective study.
|Contact: Ophira Salomon, MDemail@example.com|
|Contact: Yael Wasserzug, MDfirstname.lastname@example.org|
|Sheba Medical Center||Recruiting|
|Sub-Investigator: Irina Barequet, md|
|Sub-Investigator: Joseph Moisseiev, MD|
|Study Director:||Ophira Salomon||Sheba Medical Center|